ID   LM38-LP
AC   CVCL_B7PY
SY   LM38-Low Passage
DR   Wikidata; Q112930013
RX   PubMed=14979922;
RX   PubMed=33723318;
CC   Characteristics: Established from the mouse M38 transplantable tumor. M38 is a spontaneously arising well differentiated ductal papillary adenocarcinoma (PubMed=14979922).
CC   Doubling time: 18 +- 1.1 hours (PubMed=14979922).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B7PX ! LM38-HP
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=14979922; DOI=10.1186/bcr757; PMCID=PMC400656;
RA   Bumaschny V.F., Urtreger A.J., Diament M.J., Krasnapolski M., Fiszman G.,
RA   Klein S.M., Bal de Kier Joffe E.D.;
RT   "Malignant myoepithelial cells are associated with the differentiated
RT   papillary structure and metastatic ability of a syngeneic murine
RT   mammary adenocarcinoma model.";
RL   Breast Cancer Res. 6:R116-R129(2004).
//
RX   PubMed=33723318; DOI=10.1038/s41598-021-85344-w; PMCID=PMC7961031;
RA   Berardi D.E., Ariza Bareno L., Amigo N., Canonero L.,
RA   Pelagatti M.L.N., Motter A.N., Taruselli M.A., Diaz Bessone M.I.,
RA   Cirigliano S.M., Edelstein A., Peters M.G., Diament M.J., Urtreger A.J.,
RA   Todaro L.B.;
RT   "All-trans retinoic acid and protein kinase C alpha/beta1 inhibitor
RT   combined treatment targets cancer stem cells and impairs breast tumor
RT   progression.";
RL   Sci. Rep. 11:6044-6044(2021).
//